PERSPECTA

News from every angle

← Back to headlines

Halozyme Projects Over $1B in ENHANZE Royalties by 2026, Announces $1B Share Buyback

Halozyme Therapeutics has outlined projections for its ENHANZE royalties to exceed $1 billion by 2026 and announced a new $1 billion share buyback program.

12 May, 02:53 — 12 May, 02:53
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed86d ago

Halozyme outlines ENHANZE royalties exceeding $1B in 2026 while launching a new $1B buyback

Read full article →

Related Stories

Benue Residents Campaign for Exclusive Breastfeeding

36m ago

Promising Heart Drug Fails, Challenging Disease Theory

1h ago

Nigeria Faces Relentless Heatwave as New Normal

2h ago

Record Heatwave Grips Asia, Raising Energy Crisis and Health Concerns

2h ago